AtriCure (Nasdaq: ATRC) + shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.
Shares of ATRC fell 2.8% at $33.25 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 0.7%.
The Mason, Ohio-based company posted losses of $9.8 million. That equals 21¢ per share on sales of $106.5 million for the three months ended Dec. 31, 2023. AtriCure recorded a bottom-line slide deeper into the red despite sales growth of 21%.
Losses per share of 21¢ came in 2¢ ahead of expectations on Wall Street. Sales topped projections of $103.7 million in revenue as well.
The company highlighted growth drivers including sales for its EPi-Sense, AtriClip Flex V, Encompass clamp and cryoSphere probe. With a more than 20% revenue uptick from the fourth quarter of last year, the company a…